Terry B. Ernest

1.5k total citations
25 papers, 1.1k citations indexed

About

Terry B. Ernest is a scholar working on Pediatrics, Perinatology and Child Health, Economics and Econometrics and Pharmaceutical Science. According to data from OpenAlex, Terry B. Ernest has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pediatrics, Perinatology and Child Health, 6 papers in Economics and Econometrics and 5 papers in Pharmaceutical Science. Recurrent topics in Terry B. Ernest's work include Pharmaceutical studies and practices (17 papers), Pharmaceutical Economics and Policy (5 papers) and Child Nutrition and Feeding Issues (3 papers). Terry B. Ernest is often cited by papers focused on Pharmaceutical studies and practices (17 papers), Pharmaceutical Economics and Policy (5 papers) and Child Nutrition and Feeding Issues (3 papers). Terry B. Ernest collaborates with scholars based in United Kingdom, Switzerland and United States. Terry B. Ernest's co-authors include Catherine Tuleu, Felipe L. Lopez, Mine Orlu Gul, Fang Liu, Sejal R. Ranmal, Hannah Batchelor, Jennifer Walsh, Talia Flanagan, Mine Orlu-Gul and David Clapham and has published in prestigious journals such as Scientific Reports, International Journal of Pharmaceutics and Drugs.

In The Last Decade

Terry B. Ernest

24 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Terry B. Ernest United Kingdom	17	574	338	130	115	97	25	1.1k
Talia Flanagan United Kingdom	18	282 0.5×	550 1.6×	96 0.7×	57 0.5×	45 0.5×	42	1.1k
Viviane Klingmann Germany	11	504 0.9×	163 0.5×	74 0.6×	131 1.1×	83 0.9×	21	698
Sejal R. Ranmal United Kingdom	10	290 0.5×	150 0.4×	166 1.3×	67 0.6×	49 0.5×	16	677
Felipe L. Lopez United Kingdom	10	224 0.4×	206 0.6×	73 0.6×	54 0.5×	23 0.2×	11	550
Mine Orlu Gul United Kingdom	11	170 0.3×	206 0.6×	117 0.9×	47 0.4×	25 0.3×	35	679
Diana A. van Riet‐Nales Netherlands	13	412 0.7×	90 0.3×	60 0.5×	70 0.6×	157 1.6×	26	703
Alison Haywood Australia	19	361 0.6×	67 0.2×	32 0.2×	99 0.9×	52 0.5×	70	940
Smita Salunke United Kingdom	11	325 0.6×	77 0.2×	55 0.4×	39 0.3×	42 0.4×	29	489
Jean‐Paul Remon Belgium	21	152 0.3×	276 0.8×	67 0.5×	32 0.3×	41 0.4×	33	1.1k
Eva Benfeldt Denmark	23	111 0.2×	487 1.4×	47 0.4×	40 0.3×	34 0.4×	40	1.9k

Countries citing papers authored by Terry B. Ernest

Since Specialization

Citations

This map shows the geographic impact of Terry B. Ernest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terry B. Ernest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terry B. Ernest more than expected).

Fields of papers citing papers by Terry B. Ernest

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Terry B. Ernest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terry B. Ernest. The network helps show where Terry B. Ernest may publish in the future.

Co-authorship network of co-authors of Terry B. Ernest

This figure shows the co-authorship network connecting the top 25 collaborators of Terry B. Ernest. A scholar is included among the top collaborators of Terry B. Ernest based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Terry B. Ernest. Terry B. Ernest is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Buchanan, Ann M., Adrie Bekker, Hardik Chandasana, et al.. (2024). Advancing research and development of anti-infectives for children with a focus on antiretroviral therapy: A clinical development perspective. International Journal of Antimicrobial Agents. 64(4). 107306–107306. 1 indexed citations

Tuleu, Catherine, et al.. (2022). Opportunities for enteral drug delivery for neonates, infants, and toddlers: a critical exploration. Expert Opinion on Drug Delivery. 19(5). 475–519. 8 indexed citations

Vélez, Iván Darío, Tran Tinh Hien, Justin A. Green, et al.. (2021). Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trial. The Lancet Child & Adolescent Health. 6(2). 86–95. 7 indexed citations

Edwards, Andrew J., et al.. (2020). ‘Big Data’ informed drug development: a case for acceptability. Drug Discovery Today. 26(4). 865–869. 2 indexed citations

Goyal, Navin, Khadeeja Mohamed, Katie Rolfe, et al.. (2018). Application of the Stable Isotope Label Approach in Clinical Development—Supporting Dissolution Specifications for a Commercial Tablet Product with Tafenoquine, a Long Half-life Compound. The AAPS Journal. 20(4). 74–74. 12 indexed citations

Lopez, Felipe L., Punam Mistry, Hannah Batchelor, et al.. (2018). Acceptability of placebo multiparticulate formulations in children and adults. Scientific Reports. 8(1). 9210–9210. 29 indexed citations

Dziemidowicz, Karolina, Felipe L. Lopez, Andrew J. Edwards, et al.. (2018). Co-Processed Excipients for Dispersible Tablets—Part 2: Patient Acceptability. AAPS PharmSciTech. 19(6). 2646–2657. 27 indexed citations

Dziemidowicz, Karolina, Felipe L. Lopez, Mine Orlu, et al.. (2018). Co-Processed Excipients for Dispersible Tablets–Part 1: Manufacturability. AAPS PharmSciTech. 19(6). 2598–2609. 48 indexed citations

Walsh, Jennifer, Sejal R. Ranmal, Terry B. Ernest, & Fang Liu. (2017). Patient acceptability, safety and access: A balancing act for selecting age-appropriate oral dosage forms for paediatric and geriatric populations. International Journal of Pharmaceutics. 536(2). 547–562. 73 indexed citations

10.

Ernest, Terry B., et al.. (2016). Non-human tools for the evaluation of bitter taste in the design and development of medicines: a systematic review. Drug Discovery Today. 21(7). 1170–1180. 44 indexed citations

11.

Hanning, Sara M., Felipe L. Lopez, Ian Chi Kei Wong, et al.. (2016). Patient centric formulations for paediatrics and geriatrics: Similarities and differences. International Journal of Pharmaceutics. 512(2). 355–359. 44 indexed citations

12.

Batchelor, Hannah, Terry B. Ernest, Talia Flanagan, et al.. (2016). Towards the development of a paediatric biopharmaceutics classification system: Results of a survey of experts. International Journal of Pharmaceutics. 511(2). 1151–1157. 16 indexed citations

13.

Lopez, Felipe L., et al.. (2016). Effect of formulation variables on oral grittiness and preferences of multiparticulate formulations in adult volunteers. European Journal of Pharmaceutical Sciences. 92. 156–162. 58 indexed citations

14.

Lopez, Felipe L., Terry B. Ernest, Catherine Tuleu, & Mine Orlu Gul. (2015). Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms. Expert Opinion on Drug Delivery. 12(11). 1727–1740. 191 indexed citations

15.

Liu, Fang, Sejal R. Ranmal, Hannah Batchelor, et al.. (2015). Formulation factors affecting acceptability of oral medicines in children. International Journal of Pharmaceutics. 492(1-2). 341–343. 37 indexed citations

16.

Liu, Fang, Sejal R. Ranmal, Hannah Batchelor, et al.. (2014). Patient-Centered Pharmaceutical Design to Improve Acceptability of Medicines: Similarities and Differences in Paediatric and Geriatric Populations. Drugs. 74(16). 1871–1889. 173 indexed citations

17.

Batchelor, Hannah, et al.. (2013). Application of in vitro biopharmaceutical methods in development of immediate release oral dosage forms intended for paediatric patients. European Journal of Pharmaceutics and Biopharmaceutics. 85(3). 833–842. 38 indexed citations

18.

Ernest, Terry B., et al.. (2012). A benefit/risk approach towards selecting appropriate pharmaceutical dosage forms – An application for paediatric dosage form selection. International Journal of Pharmaceutics. 435(2). 115–123. 50 indexed citations

19.

Ernest, Terry B., Anthony J Nunn, Smita Salunke, et al.. (2012). Preparation of medicines for children – A hierarchy of classification. International Journal of Pharmaceutics. 435(2). 124–130. 43 indexed citations

20.

Ernest, Terry B., et al.. (2010). Specific aspects of gastro-intestinal transit in children for drug delivery design. International Journal of Pharmaceutics. 395(1-2). 37–43. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact